Equillium_FullColor_RGB-300 - transparent.png
Equillium to Present at Leerink Partners Global Healthcare Conference
21 févr. 2019 16h07 HE | Equillium
LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce...
Equillium Logo.png
Equillium to Host Business Update Call on February 26
19 févr. 2019 16h07 HE | Equillium
LA JOLLA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, will be hosting a call with...
keyboard_arrow_left Page précédente